Pulmonary hypertension associated with interstitial lung disease (PH-ILD) is a complex condition due to the overlap of two distinct, often progressive, disease courses. The development of PH in ILD impacts symptoms, functional status, economic burden, and mortality rates to a greater degree than ILD alone. Tune in to this multi-accredited video-based activity to hear a PH-ILD expert and a managed care expert discuss the latest diagnostic and treatment advances in PH-ILD care. A compelling testimonial will highlight one patient’s lived experience with the symptom burden of PH-ILD and serve as a reflection point for the discussion. The faculty will explore the etiology, pathophysiology, and diagnostic challenges of the condition. Recent updates to the PH-ILD treatment landscape and their implications for managed care professionals will also be discussed.This activity is delivered in partnership with phaware.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/aligning-payer-decision-making-latest-advances-diagnosis-treatment-ph-ild
- Start Date: 2024-09-13 05:00:00
- End Date: 2024-09-13 05:00:00
- Credit Details: AAPA Category 1 Credit™️: 0.5 hours
AMA PRA Category 1 Credit™️: 0.5 hours
Nursing: 0.5 hours
Pharmacy: 0.5 hours - Commercial Support: Source: United Therapeutics - Amount: 65000.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all